Clinical trial
Efficacy of Amodiaquine-artesunate in Children Aged 6-59 Months With…
NCT00425763 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00425763 |
|---|---|
| Title | Efficacy of Amodiaquine-artesunate in Children Aged 6-59 Months With Uncomplicated P. Falciparum Malaria |
| Official title | Efficacy of Amodiaquine-artesunate in the Treatment of Symptomatic, Uncomplicated Plasmodium Falciparum Malaria Among 6-59 Month Old Children at an IPTi Site in Rural Western Kenya |
| Acronym | IPTi DRWG |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | London School of Hygiene and Tropical Medicine Kenya Medical Research Institute |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | AQAS |
| Enrollment | 110 |
| Start date | May 1, 2007 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Jan 23, 2007 |
| Last update posted | Apr 5, 2012 |
| Countries | Kenya |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: